Protocol for the examination of specimens from pediatric and adult patients with osseous and extraosseous Ewing sarcoma family of tumors, including peripheral primitive neuroectodermal tumor and Ewing sarcoma

Archives of Pathology and Laboratory Medicine

Volumn 129, Issue 7, 2005, Pages 866-873

  Carpentieri, David F ^a   Qualman, Stephen J ^b,e   Bowen, Jay ^b   Krausz, Thomas ^c   Marchevsky, Alberto ^d   Dickman, Paul S ^a  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE BIOPSY; CANCER GRADING; CANCER STAGING; CELL STRUCTURE; CHROMOSOME TRANSLOCATION; CYTOLOGY; ELECTRON MICROSCOPY; EWING SARCOMA; HUMAN; LYMPH NODE METASTASIS; MICROSCOPY; NEEDLE BIOPSY; NEUROECTODERM TUMOR; OSTEOSARCOMA; PRACTICE GUIDELINE; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE FIXATION; ADULT; BONE TUMOR; CHILD; CLASSIFICATION; CLINICAL PROTOCOL; PATHOLOGY; REVIEW; SOFT TISSUE TUMOR;

ADULT; BONE NEOPLASMS; CHILD; CLINICAL PROTOCOLS; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; SARCOMA, EWING'S; SOFT TISSUE NEOPLASMS;

EID: 21344469897     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Peters MS, Reiman HM, Muller SA. Cutaneous extraskeletal Ewing's sarcoma. J Cutan Pathol. 1985;12:476-485.
2. Stechschulte SU, Kepes JJ, Holladay FB, McKittrick RJ. Primary meningeal extraosseous Ewing's sarcoma: case report. Neurosurgery, 1994;35:143-147.
3. Coffin CM, Dehner LP. Pathologic evaluation of pediatric soft tissue tumors. Am J Clin Pathol. 1998;109(suppl 1):S38-S52.
4. Qualman SJ, Moroni RA. Risk assignment in pediatric soft-tissue sarcoma: an evolving molecular classification. Curr Oncol Rep. 2002;4:123-130.
5. Ambros IM, Ambros PF, Strehl S, Kovar H, Cadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumor: evidence for a common histogenesis of Ewing's sarcoma and peripheral neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer. 1992;67:1886-1893.
6. Dickman PS. Ewing's sarcoma/primitive neuroectodermal tumor: case review. Pathol Case Rev. 2000;5:60-70.
7. Jimenez RE, Folpe AL, Lapham RL, et al. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol. 2002;26:320-327.
8. Folpe AL, Chand EM, Goldblum JR, Weiss SW. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol. 2001;25:1061-1066.
9. Folpe AL, Hill CE, Parham DM, O'Shea PA, Weiss SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol. 2000;24:1657-1662.
10. De Alava E, Kawai A, Healey JH, et al. EWS-FL11 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol. 1998;16:1248-1255.
11. Weiss SW, Goldblum JR. Primitive neuroectodermal tumors and related lesions. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. 4th ed. St Louis, Mo: Mosby; 2001:1289-1308.
12. Cost MJ, Campman SC, Davis RL, et al. Fine needle aspiration cytology of sarcoma: retrospective review of diagnostic utility and specificity. Diagn Cytopathol. 1996;15:23-32.
13. Shives TC. Biopsy of soft-tissue tumors. Clin Orthop. 1993;289:32-35.
14. Conrad EU, Bradford L, Chonsky HA. Pediatric soft tissue sarcomas. Orthop Clin North Am. 1996;27:655-664.
15. Patterson K. The pathologic handling of skeletal tumors. Am J Clin Pathol. 1998;109(suppl 1):S53-S66.
16. Marcus KC, Grier HE, Shamberger RC, et al. Childhood soft tissue sarcoma: a 20-year experience. J Pediatr. 1997;131:603-607.
17. Fletcher C, Kempson RL, Weiss S. Recommendations for reporting soft tissue sarcomas. Am J Clin Pathol. 1999;111:594-598.
18. Grier HE, Krailo MD, Tarbell, NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694-701.
19. Winkler K, Bielack S, Delling G, et al. Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer. 1990;66:1703-1710.
20. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 1977;101:14-18.
21. Schoedel K, Dickman PS, Krailo M, Perlman EJ, Miser I, Grier H. Histologic response to chemotherapy and prognosis in osseous Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) [abstract], Int J Surg Pathol. 1995;2(suppl):443.
22. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
23. Sobin LH, Wittekind C. Tumours of bone and soft tissues. In: Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002:109-118.
24. Unni KK, Dahlin DC, eds. Dahlin's Bone Tumors. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1996.